Page last updated: 2024-10-26

profenamine and Parkinsonian Disorders

profenamine has been researched along with Parkinsonian Disorders in 7 studies

profenamine: was heading 1972-94 (see under PHENOTHIAZINES 1972-90); use PHENOTHIAZINES to search ETHOPROPAZINE 1972-94
profenamine : A member of the class of phenothiazines that is phenothiazine in which the hydrogen attached to the nitrogen is substituted by a 2-(diethylamino)propyl group. An antimuscarinic, it is used as the hydrochloride for the symptomatic treatment of Parkinson's disease.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GILLHESPY, RO1
ZIEGLER, DK1
TORRES, F1
BOVET, D1
DUREL, P1
LONGO, V1
GARAI, O1
GALLAGHER, DJ2
PALMER, H2
LEBLOND, S1
PICHETTE, R1

Other Studies

7 other studies available for profenamine and Parkinsonian Disorders

ArticleYear
Lysivane in the treatment of Parkinsonism.
    Edinburgh medical journal, 1953, Volume: 60, Issue:8

    Topics: Antipsychotic Agents; Heterocyclic Compounds; Parkinson Disease; Parkinsonian Disorders; Phenothiazi

1953
Parsidol in the treatment of parkinsonism.
    Neurology, 1955, Volume: 5, Issue:3

    Topics: Antipsychotic Agents; Parkinson Disease; Parkinsonian Disorders; Phenothiazines

1955
[Antagonism of dibenzothiazine derivatives (diparcol, parsidol, phenergan) towards the central effects of nicotine; correspondence with clinical experimentation in Parkinson's disease].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1950, Volume: 144, Issue:7-8

    Topics: Empirical Research; Histamine Antagonists; Nicotine; Parkinson Disease; Parkinsonian Disorders; Phen

1950
Lysivane and artane in the treatment of parkinsonism.
    Lancet (London, England), 1951, Feb-24, Volume: 1, Issue:6652

    Topics: Parkinsonian Disorders; Phenothiazines; Trihexyphenidyl

1951
A comparative study of the use of artane and lysivane in the treatment of parkinsonism.
    The New Zealand medical journal, 1950, Volume: 49, Issue:273

    Topics: Parkinsonian Disorders; Phenothiazines; Trihexyphenidyl

1950
[Trial treatment of Parkinson's disease].
    Laval medical, 1951, Volume: 16, Issue:2

    Topics: Diphenhydramine; Parkinson Disease; Parkinsonian Disorders; Phenothiazines

1951
Lysivane therapy for parkinsonism.
    British medical journal, 1950, Sep-02, Volume: 2, Issue:4678

    Topics: Humans; Parkinsonian Disorders; Phenothiazines

1950